Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

High Resolution Genome Wide DNA Methylation Analysis in a Large Trial Group Reveals a Novel Epigenetically Defined Subgroup of Myeloma Patients Characterized By Developmental Gene Hypermethylation

Martin F Kaiser, MD, Alexander Murison, PhD, Charlotte Pawlyn, MBBChir, Eileen M Boyle, MD, David C Johnson, PhD, Brian A Walker, PhD, Ping Wu, MBBS, MSc, Dil Begum, BSc, Nasrin Dahir, BSc, Christopher P Wardell, PhD, Paula Proszek, MSc, David A Cairns, PhD, Walter Gregory, PhD, Graham Jackson, MD, Roger G Owen, MD, Gordon Cook, MD PhD, Mark T Drayson, MDPhD, Faith E Davies, MD, Gareth J. Morgan, MD PhD

Blood (2014) 124 (21): 2189.

https://doi.org/10.1182/blood.V124.21.2189.2189

Published: 2014

Journal Articles

Multiple Myeloma Cells Express Functional E-Selectin Ligands Which Can be Inhibited Both in-Vitro and in-Vivo Leading to Prolongation of Survival in a Murine Transplant Model

Alessandro Natoni, PhD, Michele Moschetta, MD, Siobhan Glavey, MD, Ping Wu, MBBS, MSc, Gareth J. Morgan, MD PhD, Lokesh Joshi, PhD, John L. Magnani, PhD, Irene M. Ghobrial, MD, Michael E O'Dwyer, MD FRCPI, FRCPath

Blood (2014) 124 (21): 4718.

https://doi.org/10.1182/blood.V124.21.4718.4718

Published: 2014

Journal Articles

Low Expression Of The FUCA1 Gene Is An Adverse Prognostic Factor In Myeloma and Combined With High Sialyltransferase Gene Expression Identifies Patients At Increased Risk Of Early Disease Progression and Death

Siobhan Glavey, MD, Ping Wu, MBBS, MSc, Laura S Murillo, PhD, Catherine Loughrey, MSc, Aldo M Roccaro, MD, PhD, Gareth J Morgan, MD PhD, Irene M. Ghobrial, MD, Lokesh Joshi, PhD, Michael E O'Dwyer, MD, FRCPI, FRCPath

Blood (2013) 122 (21): 1864.

https://doi.org/10.1182/blood.V122.21.1864.1864

Published: 2013

Journal Articles

Genome-Wide Methylation and Gene Expression Analyses Identify Patients At High and Low Risk of Disease Progression

Martin F Kaiser, MD, David C Johnson, PhD, Brian A Walker, BSc, PhD, Ping Wu, MBBS, MSc, Christopher P Wardell, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD

Blood (2012) 120 (21): 319.

https://doi.org/10.1182/blood.V120.21.319.319

Published: 2012

Journal Articles

The Impact of Thalidomide Maintenance Therapy Varies Dependent Upon Biological Risk Grouping

Annamaria Brioli, MD, Fiona M Ross, DPhil, Martin F Kaiser, MD, Charlotte Pawlyn, MD, Ping Wu, MBBS, MSc, Walter M Gregory, PhD, Roger G Owen, MD, Graham H Jackson, MD, Michele Cavo, MD, Faith E. Davies, MD, Gareth J. Morgan, MD PhD

Blood (2012) 120 (21): 199.

https://doi.org/10.1182/blood.V120.21.199.199

Published: 2012

Journal Articles

Glycosylation-Related Gene Expression Is Dysregulated in Multiple Myeloma and Overexpression of the Sialyltransferase ST3GAL6 Is Associated with Inferior Survival.

Siobhan V Glavey, M.B., BCh, BAO, BSc, Stephen Cunningham, PhD, Laura S Murillo, PhD, Catherine Loughrey, MSc, Ping Wu, MBBS, MSc, Michael Cairns, PhD, Satbir Kaur Gill, MSc, Anja Kruger, MSc, Jared Q Gerlach, PhD, Marian Kane, PhD, Gareth J. Morgan, MD PhD, Lokesh Joshi, PhD, Michael E O'Dwyer, MD, FRCPI, FRCPath

Blood (2012) 120 (21): 2931.

https://doi.org/10.1182/blood.V120.21.2931.2931

Published: 2012

Journal Articles

The Natural History of Myeloma Patients Who Relapse Early After High Dose Therapy.

Nory Holle, Ping Wu, MBBS, MSc, Charlotte Pawlyn, MD, Radovan Saso, MD, MPhil, PhD, Jennifer G. Treleaven, MD, Michael Potter, MD PhD, Mark E Ethell, MD, Bronwen E. Shaw, MD PhD, Walter M Gregory, PhD, Sandra Croockewit, MD, Gareth J. Morgan, MD PhD, Faith E. Davies, MD

Blood (2012) 120 (21): 3125.

https://doi.org/10.1182/blood.V120.21.3125.3125

Published: 2012

Journal Articles

Improved Risk Stratification in Myeloma Using Microrna-Based Classifier

Ping Wu, MBBS, MSc, Luca Agnelli, PhD, Brian A Walker, BSc, PhD, Katia Todoerti, David C Johnson, PhD, Martin Kaiser, MD, Christopher P Wardell, PhD, Walter M Gregory, PhD, Faith E. Davies, MD, Daniel Brewer, PhD, Antonino Neri, Gareth J. Morgan, MD PhD

Blood (2012) 120 (21): 932.

https://doi.org/10.1182/blood.V120.21.932.932

Published: 2012

NARROW

High Resolution Genome Wide DNA Methylation Analysis in a Large Trial Group Reveals a Novel Epigenetically Defined Subgroup of Myeloma Patients Characterized By Developmental Gene Hypermethylation

Multiple Myeloma Cells Express Functional E-Selectin Ligands Which Can be Inhibited Both in-Vitro and in-Vivo Leading to Prolongation of Survival in a Murine Transplant Model

Low Expression Of The FUCA1 Gene Is An Adverse Prognostic Factor In Myeloma and Combined With High Sialyltransferase Gene Expression Identifies Patients At Increased Risk Of Early Disease Progression and Death

Genome-Wide Methylation and Gene Expression Analyses Identify Patients At High and Low Risk of Disease Progression

The Impact of Thalidomide Maintenance Therapy Varies Dependent Upon Biological Risk Grouping

Glycosylation-Related Gene Expression Is Dysregulated in Multiple Myeloma and Overexpression of the Sialyltransferase ST3GAL6 Is Associated with Inferior Survival.

The Natural History of Myeloma Patients Who Relapse Early After High Dose Therapy.

Improved Risk Stratification in Myeloma Using Microrna-Based Classifier

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only